These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37716254)

  • 1. Botulinum toxin treatment of the buccinator muscle facial synkinesis: A systematic review.
    de Jongh FW; Wolf O; Wong ZY; Ingels KJAO; Pouwels S
    J Plast Reconstr Aesthet Surg; 2023 Nov; 86():88-93. PubMed ID: 37716254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
    Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target.
    Wei LA; Diels J; Lucarelli MJ
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buccinator synkinesis treated by botulinum toxin in facial palsy and hemifacial spasms.
    Kanerva M
    J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1464-1469. PubMed ID: 33358465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Buccinator muscle: A new target for botulinum toxin injections in the treatment of facial paralysis sequelae].
    Lacroix G; Duquennoy-Martinot V; Guerreschi P
    Ann Chir Plast Esthet; 2022 Jun; 67(3):125-132. PubMed ID: 35662477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin Type A Injection in the Treatment of Postparetic Facial Synkinesis: An Integrative Review.
    Tavares H; Oliveira M; Costa R; Amorim H
    Am J Phys Med Rehabil; 2022 Mar; 101(3):284-293. PubMed ID: 35175961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A treatment in facial palsy synkinesis: a systematic review and meta-analysis.
    de Jongh FW; Schaeffers AWMA; Kooreman ZE; Ingels KJAO; van Heerbeek N; Beurskens C; Monstrey SJ; Pouwels S
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1581-1592. PubMed ID: 36544062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: "Treating Buccinator with Botulinum Toxin in Patients with Facial Synkinesis: A Previously Overlooked Target".
    Chundury RV; Perry JD
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):70. PubMed ID: 26735958
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply re: "Treating Buccinator with Botulinum Toxin in Patients with Facial Synkinesis: A Previously Overlooked Target".
    Lucarelli MJ; Wei LA; Diels J
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):70-1. PubMed ID: 26735959
    [No Abstract]   [Full Text] [Related]  

  • 10. Platysma synkinesis in facial palsy and botulinum toxin type A.
    Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
    Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.
    Shinn JR; Nwabueze NN; Du L; Patel PN; Motamedi KK; Norton C; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2019 May; 21(3):244-251. PubMed ID: 30703206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
    Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A.
    Cecini M; Pavese C; Comelli M; Carlisi E; Sala V; Bejor M; Toffola ED
    Plast Reconstr Surg; 2013 Nov; 132(5):1255-1264. PubMed ID: 24165606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis.
    Choi KH; Rho SH; Lee JM; Jeon JH; Park SY; Kim J
    J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1058-63. PubMed ID: 23683725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis.
    Filipo R; Spahiu I; Covelli E; Nicastri M; Bertoli GA
    Laryngoscope; 2012 Feb; 122(2):266-70. PubMed ID: 22252570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin in Facial Reanimation: Map of the Facial Musculature and Dosage.
    VandeWater T; Hetzler L
    Atlas Oral Maxillofac Surg Clin North Am; 2023 Mar; 31(1):71-83. PubMed ID: 36754509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An objective assessment of botulinum toxin type A injection in the treatment of post-facial palsy synkinesis and hyperkinesis using the synkinesis assessment questionnaire.
    Neville C; Venables V; Aslet M; Nduka C; Kannan R
    J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1624-1628. PubMed ID: 28688864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy with botulinum toxin in facial synkinesis: Retrospective data analysis of data from 1998 to 2018.
    Alipour S; Pick C; Jansen S; Rink S; Klußmann JP; Grosheva M
    Clin Otolaryngol; 2021 Jul; 46(4):758-766. PubMed ID: 33534183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin].
    Winterhoff J; Laskawi R
    HNO; 2012 Jun; 60(6):479-83. PubMed ID: 22669435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular retraining therapy combined with preceding botulinum toxin A injection for chronic facial paralysis.
    Jeong J; Lee JM; Kim J
    Acta Otolaryngol; 2023 May; 143(5):446-451. PubMed ID: 37173287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.